Frank Rimerman Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Buy
573
+39
+7% +$21.9K 0.02% 522
2026
Q1
$300K Sell
534
-461
-46% -$296K 0.02% 496
2025
Q4
$673K Buy
995
+444
+81% +$302K 0.04% 311
2025
Q3
$352K Buy
551
+53
+11% +$32.2K 0.02% 446
2025
Q2
$267K Sell
498
-252
-34% -$121K 0.02% 483
2025
Q1
$315K Buy
750
+235
+46% +$102K 0.03% 398
2024
Q4
$213K Sell
515
-20
-4% -$8.77K 0.02% 494
2024
Q3
$270K Buy
535
+15
+3% +$7.29K 0.02% 447
2024
Q2
$253K Buy
+520
New +$261K 0.02% 481

Other funds holding IDXX

Frank Rimerman Advisors's IDXX Position: Q2 2026 in Review

Frank Rimerman Advisors increased its Idexx Laboratories (IDXX) stake by 7.3% in Q2 2026, buying an estimated $21.9K and bringing the position to 573 shares worth $302K. The position accounts for 0.02% of the portfolio, ranked #522.

Frank Rimerman Advisors first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $673K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Frank Rimerman Advisors held 573 shares of Idexx Laboratories worth $302K as of Q2 2026.
  • Frank Rimerman Advisors bought 39 Idexx Laboratories shares in Q2 2026, an estimated $21.9K.
  • Idexx Laboratories made up 0.02% of Frank Rimerman Advisors's portfolio in Q2 2026, its #522 holding.
  • Frank Rimerman Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Frank Rimerman Advisors's Idexx Laboratories position peaked at $673K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.